As mentioned in the intro, our owner is a chemical (license holder), graduate, experienced cum authorized in the medicine field, also availing services of various other medicine- doctors. To help the consumers in choosing best medicine of same salts and also finding their alternatives with dual-salts. We have also tried to make the consumers know about pros and cons (side effects), maximum time of consumption of a medicine, suggestion about a higher dose in case of no-satisfactory results, with each medicine.

Our company is procuring all the medicine directly from its manufacturer and only through valid channels or distributers and dealers, ensuring supply of 100% genuine and pure medicines to our customers, so that they can trust and have full faith & confidence before use.

Lastly, basing upon the long list of our old and satisfied clients, anyone, can be sure about the safety of the money paid by him/her. We always try our best to supply all the stuff in safe and fastest possible, time frame.

Consumers are free to contact and discuss about best lowest prices at the time of placing orders.

The following is the list of medicines approved for various Cancers/Liver Disorders etc. The list is for information purpose only. Please consult your doctor before starting any medication.

Drugs Approved for Acute Lymphoblastic Leukemia (ALL)

• Asparaginase Erwinia chrysanthemi
• Blinatumomab
• Clofarabine
• Cyclophosphamide
• Cytarabine
• Dasatinib
• Daunorubicin Hydrochloride
• Doxorubicin Hydrochloride
• Inotuzumab Ozogamicin
• Imatinib Mesylate
• Mercaptopurine
• Methotrexate
• Nelarabine
• Pegaspargase
• Ponatinib Hydrochloride
• Prednisone
• Tisagenlecleucel
• Vincristine Sulfate
• Vincristine Sulfate Liposome

Drugs Approved for Acute Myeloid Leukemia (AML)

• Arsenic Trioxide
• Cyclophosphamide
• Cytarabine
• Daunorubicin Hydrochloride
• Daunorubicin Hydrochloride and Cytarabine Liposome
• Doxorubicin Hydrochloride
• Enasidenib Mesylate
• Idarubicin Hydrochloride
• Midostaurin
• Mitoxantrone Hydrochloride
• Thioguanine
• Vincristine Sulfate

Drugs Approved for Chronic Lymphocytic Leukemia (CLL)

• Alemtuzumab
• Bendamustine Hydrochloride
• Chlorambucil
• Cyclophosphamide
• Fludarabine Phosphate
• Ibrutinib
• Idelalisib
• Mechlorethamine Hydrochloride
• Obinutuzumab
• Ofatumumab
• Prednisone
• Rituximab
• Rituximab and Hyaluronidase Human
• Venetoclax

Drugs Approved for Chronic Myelogenous Leukemia (CML)

• Bosutinib
• Busulfan
• Cyclophosphamide
• Cytarabine
• Dasatinib
• Hydroxyurea
• Imatinib Mesylate
• Mechlorethamine Hydrochloride
• Nilotinib
• Omacetaxine Mepesuccinate
• Ponatinib Hydrochloride

Drugs Approved for Hairy Cell Leukemia

• Cladribine
• Recombinant Interferon Alfa-2b

Drugs Approved for Mast Cell Leukemia

• Midostaurin

Drugs Approved for Meningeal Leukemia

• Cytarabine

Drugs Approved for Stomach (Gastric) Cancer

• Docetaxel
• Doxorubicin Hydrochloride
• Fluorouracil Injection
• Mitomycin C
• Ramucirumab
• Trastuzumab

Drugs Approved for Gastroenteropancreatic Neuroendocrine Tumors

• Everolimus
• Lanreotide Acetate

Drugs Approved for Brain Tumors

• Bevacizumab
• Carmustine
• Everolimus
• Lomustine
• Temozolomide

Drugs Approved to Prevent Breast Cancer

• Raloxifene Hydrochloride
• Tamoxifen Citrate

Drugs Approved to Treat Breast Cancer

• Abemaciclib
• Anastrozole
• Capecitabine
• Docetaxel
• Doxorubicin Hydrochloride
• Epirubicin Hydrochloride
• Eribulin Mesylate
• Everolimus
• Exemestane
• Fluorouracil Injection
• Fulvestrant
• Gemcitabine Hydrochloride
• Goserelin Acetate
• Ixabepilone
• Lapatinib Ditosylate
• Letrozole
• Megestrol Acetate
• Methotrexate
• Neratinib Maleate
• Olaparib
• Paclitaxel
• Paclitaxel Albumin-stabilized Nanoparticle Formulation
• Palbociclib
• Pamidronate Disodium
• Pertuzumab
• Ribociclib
• Tamoxifen Citrate
• Thiotepa
• Toremifene
• Trastuzumab
• Vinblastine Sulfate

Drugs Approved for Colon Cancer

• Bevacizumab
• Capecitabine
• Cetuximab
• Fluorouracil Injection
• Irinotecan Hydrochloride
• Leucovorin Calcium
• Nivolumab
• Oxaliplatin
• Panitumumab
• Ramucirumab
• Regorafenib
• Trifluridine and Tipiracil Hydrochloride
• Ziv-Aflibercept

Drugs Approved for Rectal Cancer

• Bevacizumab
• Capecitabine
• Cetuximab
• Fluorouracil Injection
• Irinotecan Hydrochloride
• Leucovorin Calcium
• Nivolumab
• Oxaliplatin
• Panitumumab
• Ramucirumab
• Regorafenib
• Trifluridine and Tipiracil Hydrochloride
• Ziv-Aflibercept

Drugs Approved for Kidney (Renal Cell) Cancer

• Aldesleukin
• Axitinib
• Bevacizumab
• Cabozantinib-S-Malate
• Everolimus
• Ipilimumab
• Lenvatinib Mesylate
• Nivolumab
• Pazopanib Hydrochloride
• Sorafenib Tosylate
• Sunitinib Malate
• Temsirolimus

Drugs Approved for Liver Cancer

• Regorafenib
• Sorafenib Tosylate

Drugs Approved for Non-Small Cell Lung Cancer

• Afatinib Dimaleate
• Alectinib
• Atezolizumab
• Bevacizumab
• Brigatinib
• Carboplatin
• Ceritinib
• Crizotinib
• Dabrafenib
• Docetaxel
• Erlotinib Hydrochloride
• Everolimus
• Gefitinib
• Gemcitabine Hydrochloride
• Mechlorethamine Hydrochloride
• Methotrexate
• Necitumumab
• Nivolumab
• Osimertinib
• Paclitaxel
• Paclitaxel Albumin-stabilized Nanoparticle Formulation
• Pembrolizumab
• Pemetrexed Disodium
• Ramucirumab
• Trametinib
• Vinorelbine Tartrate

Drugs Approved for Small Cell Lung Cancer

• Doxorubicin Hydrochloride
• Etoposide
• Etoposide Phosphate
• Everolimus
• Mechlorethamine Hydrochloride
• Methotrexate
• Topotecan Hydrochloride

Drugs Approved for Basal Cell Carcinoma

• 5-FU (Fluorouracil–Topical)
• Fluorouracil–Topical
• Imiquimod
• Sonidegib
• Vismodegib

Drugs Approved for Melanoma

• Aldesleukin
• Cobimetinib
• Dabrafenib
• Dacarbazine
• Ipilimumab
• Nivolumab
• Peginterferon Alfa-2b
• Pembrolizumab
• Recombinant Interferon Alfa-2b
• Talimogene Laherparepvec
• Trametinib
• Vemurafenib

Drugs Approved for Merkel Cell Carcinoma

• Avelumab

Drugs Approved for Bone Cancer

• Dactinomycin
• Denosumab
• Doxorubicin Hydrochloride
• Methotrexate

Drugs Approved for Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

• Bevacizumab
• Carboplatin
• Cisplatin
• Cyclophosphamide
• Doxorubicin Hydrochloride
• Doxorubicin Hydrochloride Liposome
• Gemcitabine Hydrochloride
• Melphalan
• Niraparib Tosylate Monohydrate
• Olaparib
• Paclitaxel
• Rucaparib Camsylate
• Thiotepa
• Topotecan Hydrochloride

Drugs Approved for Prostate Cancer

• Abiraterone Acetate
• Apalutamide
• Bicalutamide
• Cabazitaxel
• Degarelix
• Docetaxel
• Enzalutamide
• Flutamide
• Goserelin Acetate
• Leuprolide Acetate
• Mitoxantrone Hydrochloride
• Nilutamide
• Radium 223 Dichloride
• Sipuleucel-T

Drugs Approved for Head and Neck Cancer

• Bleomycin
• Cetuximab
• Docetaxel
• Hydroxyurea
• Methotrexate
• Nivolumab
• Pembrolizumab

Drugs Approved for Thyroid Cancer

• Cabozantinib-S-Malate
• Doxorubicin Hydrochloride
• Ipilimumab
• Lenvatinib Mesylate
• Nivolumab
• Sorafenib Tosylate
• Vandetanib

Drugs Approved for Esophageal Cancer

• Docetaxel
• Ramucirumab
• Trastuzumab

Drugs approved for Hepatitis B

• Entecavir
• Lamivudine
• adefovir dipivoxil
• interferon alpha-2b
• pegylated interferon
• telbivudine
• tenofovir alafenamide
• tenofovir

Drugs approved for Hepatitis C

• Ribavirin
• Daclatasvir
• Sofusbuvir
• Sofosbuvir+Ledipasvir
• Sofosbuvir+Velpatasvir
• Telaprevir
• interferon aphacon-1
• interferon alpha-2b
• glecaprevir and pibrentasvir
• simeprevir
• pegylated interferon
• pegylated interferon alpha-2b
• Ribavirin
• interferon alpha-2a
• ombitasvir, paritaprevir and ritonavir
• Boceprevir
• elbasvir, grazoprevir